HCA Healthcare (HCA) Expected to Announce Quarterly Earnings on Friday

HCA Healthcare (NYSE:HCA - Get Free Report) is anticipated to announce its Q1 2025 earnings results before the market opens on Friday, April 25th. Analysts expect HCA Healthcare to post earnings of $5.77 per share and revenue of $18.26 billion for the quarter. HCA Healthcare has set its FY 2025 guidance at 24.050-25.850 EPS.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business earned $5.90 EPS. On average, analysts expect HCA Healthcare to post $25 EPS for the current fiscal year and $28 EPS for the next fiscal year.

HCA Healthcare Stock Performance

Shares of HCA traded up $11.25 during mid-day trading on Wednesday, hitting $335.87. 1,402,111 shares of the company's stock were exchanged, compared to its average volume of 1,387,439. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $82.69 billion, a price-to-earnings ratio of 15.29, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The stock's 50-day simple moving average is $329.11 and its 200-day simple moving average is $333.15. HCA Healthcare has a 52 week low of $289.98 and a 52 week high of $417.14.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare's dividend payout ratio is presently 13.11%.

Analysts Set New Price Targets

Several brokerages have recently commented on HCA. Royal Bank of Canada dropped their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. Baird R W cut shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Bank of America lowered their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Finally, Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $381.67.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company's stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.30% of the company's stock.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in HCA Healthcare stock. Brighton Jones LLC purchased a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,402 shares of the company's stock, valued at approximately $1,021,000. 62.73% of the stock is owned by institutional investors.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.